ESR1 and colorectal carcinoma: Like the full-length ERα, the other shorter isoforms ERα-36 and ERα-46 seemed to be involved in CRC progression through activation of survival signaling pathways like PKC, ERK-MAPK, and PI3K-Akt [12,13].